S D Ramsey

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi request reprint The forest and the trees: the human costs of cancer
    Larry G Kessler
    J Natl Cancer Inst 99:2-3. 2007
  2. ncbi request reprint Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 109:2222-8. 2007
  3. pmc Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Oncologist 18:760-7. 2013
  4. pmc Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis
    Scott Ramsey
    Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Health Aff (Millwood) 32:1143-52. 2013
  5. pmc Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Wash 98109, USA
    Public Health Genomics 13:1-12. 2010
  6. pmc Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, United States
    Contemp Clin Trials 34:1-9. 2013
  7. pmc A comparison of approaches for association studies of polymorphisms and colorectal cancer risk
    S D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Colorectal Dis 14:e573-86. 2012
  8. ncbi request reprint Health insurer policies toward risk-stratified colorectal cancer screening: a survey of health plan medical directors
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North M3 B232, Seattle, WA 98109, USA
    J Insur Med 43:92-101. 2012
  9. pmc Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Urology 79:1034-41. 2012
  10. pmc Patterns of blood product use among patients with myelodysplastic syndrome
    S D Ramsey
    Research and Economic Assessment in Cancer and Healthcare REACH Group, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Vox Sang 102:331-7. 2012

Detail Information

Publications112 found, 100 shown here

  1. ncbi request reprint The forest and the trees: the human costs of cancer
    Larry G Kessler
    J Natl Cancer Inst 99:2-3. 2007
  2. ncbi request reprint Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 109:2222-8. 2007
    ..The population included Medicare patients (age >or=65 years) who were diagnosed with local or regional stage colorectal cancer between 1986 and 1996...
  3. pmc Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Oncologist 18:760-7. 2013
    ..In discussing these concepts, we also touched upon the notion of whether cancer is special among health issues with regard to how evidence is generated and used. ..
  4. pmc Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis
    Scott Ramsey
    Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Health Aff (Millwood) 32:1143-52. 2013
    ..The findings suggest that employers and governments may have a policy role to play in creating programs and incentives that could help people cover expenses in the first year following a cancer diagnosis...
  5. pmc Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Wash 98109, USA
    Public Health Genomics 13:1-12. 2010
    ..We evaluated the potential impact of hypothetical colorectal-cancer-associated gene variant testing on quality of life, health habits and cancer screening behavior...
  6. pmc Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, United States
    Contemp Clin Trials 34:1-9. 2013
    ..The process may serve as a template for future studies evaluating the comparative effectiveness of genomic tests in oncology, particularly those that are conducted within cooperative clinical trials groups...
  7. pmc A comparison of approaches for association studies of polymorphisms and colorectal cancer risk
    S D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Colorectal Dis 14:e573-86. 2012
    ..Our aim was to apply well-established quality-control criteria to individual association studies and then compare the results of meta-analyses that included or excluded studies that did not meet these criteria...
  8. ncbi request reprint Health insurer policies toward risk-stratified colorectal cancer screening: a survey of health plan medical directors
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North M3 B232, Seattle, WA 98109, USA
    J Insur Med 43:92-101. 2012
    ..We sought to determine whether health insurance coverage of colorectal cancer (CRC) screening varied based on risk...
  9. pmc Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Urology 79:1034-41. 2012
    ..To evaluate the association between complementary and alternative medicine (CAM) use, satisfaction with treatment, and patient-reported outcomes after treatment...
  10. pmc Patterns of blood product use among patients with myelodysplastic syndrome
    S D Ramsey
    Research and Economic Assessment in Cancer and Healthcare REACH Group, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Vox Sang 102:331-7. 2012
    ....
  11. ncbi request reprint Disenrollment from Medicaid after recent cancer diagnosis
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Med Care 46:49-57. 2008
    ..We examine the frequency with which newly diagnosed cancer patients are covered by Medicaid in Washington State and the duration of coverage...
  12. ncbi request reprint Updated evaluation of the cost-effectiveness of lung volume reduction surgery
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 B232, Seattle, WA 98109, USA
    Chest 131:823-32. 2007
    ..We present an updated analysis of cost-effectiveness with 1-year additional follow-up data...
  13. ncbi request reprint Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    J Manag Care Pharm 12:472-8. 2006
    ..Most cases of lung cancer are non-small cell lung cancer (NSCLC). Erlotinib monotherapy is indicated for the treatment of patients with locally advanced or metastatic NSCLC after failure of at least 1 prior chemotherapy regimen...
  14. ncbi request reprint Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Manag Care 12:197-202. 2006
    ....
  15. ncbi request reprint On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
    J Urol 177:1992-9. 2007
    ..To determine the completeness and quality of available health related quality of life information we performed a review of health related quality of life studies, assessing what information was and was not reported...
  16. pmc Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North M2 B230, P O Box 19024, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 14:2494-500. 2005
    ..Although the rationale for earlier screening of persons with a family history of colorectal cancer is plausible, there is no direct evidence that earlier assessment is either effective or cost-effective...
  17. ncbi request reprint What do we want from our investment in cancer research?
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, USA
    Health Aff (Millwood) 24:W5R101-4. 2005
    ....
  18. ncbi request reprint Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Value Health 8:521-33. 2005
    ..Its goal was to develop a guidance document for designing, conducting, and reporting cost-effectiveness analyses conducted as a part of clinical trials...
  19. ncbi request reprint Evidence, economics, and emphysema: Medicare's long journey with lung volume reduction surgery
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Health Aff (Millwood) 24:55-66. 2005
    ..We describe the implications of this study for evidence-based evaluation of surgical procedures and Medicare's potential role in evaluating experimental treatments that affect its beneficiaries...
  20. ncbi request reprint Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M2 B230, Seattle, WA 98109, USA
    J Clin Oncol 22:4971-8. 2004
    ..Using the Surveillance, Epidemiology and End Results (SEER)-Medicare database, we examined community treatment patterns for advanced NSCLC, focusing on chemotherapy...
  21. ncbi request reprint Gut check: can cost-effectiveness analysis help eliminate gastric cancer in Asia?
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, Public Health Sciences Division, 1100 Fairview Avenue North, Box 19024, M2 B230, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 16:873-4. 2007
  22. ncbi request reprint Cost effectiveness of lung volume reduction surgery
    Scott D Ramsey
    Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North MP 900, Seattle, WA 98109, USA
    Chest Surg Clin N Am 13:727-38, vii-viii. 2003
    ....
  23. ncbi request reprint An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAUniversity of Washington, Seattle, WA 98109, USA
    Pharmacoeconomics 26:329-39. 2008
    ..We estimated the cost effectiveness of atorvastatin as primary prevention against CV disease from the short-term and lifetime US payer perspectives...
  24. ncbi request reprint A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98109, USA
    Med Care 46:542-8. 2008
    ....
  25. pmc How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment
    Scott D Ramsey
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Health Aff (Millwood) 30:2259-68. 2011
    ..We suggest novel funding approaches and a systematic process for moving from regulatory approval to the generation of evidence that meets the needs of stakeholders and, ultimately, patients...
  26. doi request reprint Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M3 B232, Seattle, WA 98109 1024, USA
    World J Urol 29:3-9. 2011
    ..We hypothesized that urologists present a wider range of management recommendations and are less likely to consider the patient preference during the initial consultation...
  27. ncbi request reprint Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Manag Care 16:678-86. 2010
    ..To examine variables influencing colony-stimulating factor (CSF) prescription as primary prophylaxis versus other use during patients' initial chemotherapy course among a large sample of health insurance records...
  28. ncbi request reprint Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Urol 184:120-5. 2010
    ....
  29. ncbi request reprint A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Am J Gastroenterol 105:1861-9. 2010
    ..The aim of this study was to determine the cost-effectiveness of family history screening (FHS) for colorectal cancer (CRC) susceptibility at age 40 with early screening of those with increased risk...
  30. ncbi request reprint Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Breast J 16:20-7. 2010
    ..More effort is needed to ensure this vulnerable population receives adequate radiation following BCS...
  31. ncbi request reprint Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 B232, Seattle, WA 98109, USA
    J Manag Care Pharm 15:659-68. 2009
    ..Administrative claims are readily available, but their usefulness for identifying persons with non-small cell lung cancer (NSCLC) is relatively unknown, particularly for younger persons and those enrolled in Medicaid...
  32. pmc Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues
    Scott Ramsey
    Cancer Technology Assessment Group, Translational and Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 115:5394-403. 2009
    ..Evaluating the costs and impact of navigation will require some novel methods, but will be critical in recommendations concerning dissemination of navigation programs...
  33. pmc Access to information sources and treatment considerations among men with local stage prostate cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Urology 74:509-15. 2009
    ..Diagnosed men have access to a large number of information sources about therapy, including print and broadcast media, the Internet, books, and friends with the disease...
  34. pmc Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Oncologist 13:925-9. 2008
    ..We evaluated the proportion of registered trials that are published in the peer-reviewed literature...
  35. doi request reprint Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center and University of Washington Department of Medicine, Seattle, WA 98109, USA
    Value Health 12:217-25. 2009
    ....
  36. ncbi request reprint Second-line and third-line chemotherapy for lung cancer: use and cost
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 B232, Seattle, WA 98109 1024, USA
    Am J Manag Care 14:297-306. 2008
    ..To identify commonly prescribed first-, second-, and third-line chemotherapy regimens for persons with lung cancer and to evaluate the utilization patterns and costs of care associated with receiving these regimens...
  37. pmc Cost-effectiveness of lung volume reduction surgery
    Scott D Ramsey
    Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Proc Am Thorac Soc 5:406-11. 2008
    ....
  38. ncbi request reprint The burden of illness and economic evaluation for COPD
    S D Ramsey
    Fred Hutchinson Cancer Research Center, Dept of Pharmacy, University of Washington, Seattle, WA 98109, USA
    Eur Respir J Suppl 41:29s-35s. 2003
    ....
  39. ncbi request reprint Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109, USA
    N Engl J Med 348:2092-102. 2003
    ..The National Emphysema Treatment Trial, a randomized clinical trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, included a prospective economic analysis...
  40. ncbi request reprint Relative impact of patient and clinic factors on adherence to primary care preventive service guidelines: an exploratory study
    S D Ramsey
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Med Care 39:979-89. 2001
    ..Preventive care service use is commonly compared across health plans, clinics, or individual providers, yet little is known about the influence of the clinic versus patient factors on utilization of these services...
  41. ncbi request reprint Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer
    Scott D Ramsey
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 94:291-7. 2002
    ..There were no statistically significant differences in survival or cancer-related quality of life between the treatment arms...
  42. ncbi request reprint Does economics matter when treating advanced non-small cell lung cancer?
    Scott D Ramsey
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Oncologist 7:179-80. 2002
  43. ncbi request reprint Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer
    S D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North MP 900, Box 19024, Seattle, WA 98109, USA
    Ann Intern Med 135:577-88. 2001
    ..The National Cancer Institute has published consensus guidelines for universal screening for hereditary nonpolyposis colorectal cancer (HNPCC) in patients with newly diagnosed colorectal cancer...
  44. ncbi request reprint Design issues for conducting cost-effectiveness analyses alongside clinical trials
    S D Ramsey
    Department of Medicine, University of Washington, Seattle, Washington 98195, USA
    Annu Rev Public Health 22:129-41. 2001
    ..Many potential threats to external validity can be successfully addressed if they are identified and accounted for in the design phase of the study...
  45. ncbi request reprint Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group
    S D Ramsey
    Department of Medicine, University of Washington, Seattle, USA
    Ann Thorac Surg 71:995-1002. 2001
    ....
  46. ncbi request reprint Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Results of focus group interviews
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Public Health Sciences Division, 1100 Fairview Avenue North, MP 900, PO Box 19024, University of Washington, Seattle, WA 98109, USA
    Community Genet 6:29-36. 2003
    ..To compare knowledge of and interest in genetic testing for hereditary colon cancer syndromes...
  47. ncbi request reprint Economic evaluation of aquatic exercise for persons with osteoarthritis
    D L Patrick
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Med Care 39:413-24. 2001
    ..To estimate cost and outcomes of the Arthritis Foundation aquatic exercise classes from the societal perspective...
  48. ncbi request reprint The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study
    R Etzioni
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Health Econ 10:245-56. 2001
    ..The results emphasize the need to adopt a standard approach for dealing with future costs when evaluating lifesaving interventions for cost-effectiveness analyses...
  49. pmc Multi-modality mediastinal staging for lung cancer among medicare beneficiaries
    Farhood Farjah
    Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, WA 98195 6410, USA
    J Thorac Oncol 4:355-63. 2009
    ..It is unknown how frequently multimodality mediastinal staging is used, or whether its use is associated with better health outcomes...
  50. ncbi request reprint Completion of radiotherapy for local and regional head and neck cancer in medicare
    Megan Dann Fesinmeyer
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Arch Otolaryngol Head Neck Surg 135:860-7. 2009
    ....
  51. ncbi request reprint Optimizing sampling strategies for estimating quality-adjusted life years
    S D Ramsey
    Department of Medicine, University of Washington Medical Center, Seattle, USA
    Med Decis Making 17:431-8. 1997
    ..Such data are frequently available from disease registries, the literature, or previous studies...
  52. ncbi request reprint Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?
    Nina Oestreicher
    University of Washington, Seattle, Washington, USA
    Genet Med 7:380-9. 2005
    ..However, the outcomes associated with gene expression profiling are not clear, and guidelines for the appropriate use of genomic technologies have not been established...
  53. ncbi request reprint Simulation modeling of outcomes and cost effectiveness
    S D Ramsey
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Hematol Oncol Clin North Am 14:925-38. 2000
    ..The purpose of this article is to clarify the process of modeling, so that readers of models are more knowledgeable about their uses, strengths, and limitations...
  54. ncbi request reprint On the use of survival analysis techniques to estimate medical care costs
    R D Etzioni
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Health Econ 18:365-80. 1999
    ..Our observations are confirmed through simulations and empirical data analysis. We conclude that survival analysis approaches are not generally appropriate for the analysis of medical costs and review several valid alternatives...
  55. ncbi request reprint Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer
    Scott D Ramsey
    Department of Medicine, University of Washington, Seattle, USA
    Am J Gastroenterol 97:440-5. 2002
    ..We aimed to determine cancer-related medical care costs for long term survivors of colorectal cancer...
  56. ncbi request reprint Effect of improved glycemic control on health care costs and utilization
    E H Wagner
    MacColl Institute for Healthcare Innovation, Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Suite 1290, Seattle, WA 98101, USA
    JAMA 285:182-9. 2001
    ..Because of the additional costs associated with improving diabetes management, there is interest in whether improved glycemic control leads to reductions in health care costs, and, if so, when such cost savings occur...
  57. ncbi request reprint Patient-level estimates of the cost of complications in diabetes in a managed-care population
    S D Ramsey
    Department of Medicine, University of Washington, Seattle, USA
    Pharmacoeconomics 16:285-95. 1999
    ..To develop incidence-based estimates of the cost of several diabetes-related complications...
  58. doi request reprint The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer
    Josh J Carlson
    School of Pharmacy, University of Washington, Seattle, WA 98195, USA
    Value Health 12:20-7. 2009
    ..The objective of this study was to evaluate the potential cost-utility of implementing epidermal growth factor receptor (EGFR) testing before initiating second-line therapy for advanced refractory non-small-cell lung cancer (NSCLC)...
  59. ncbi request reprint Measuring costs: administrative claims data, clinical trials, and beyond
    Ruth Etzioni
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Med Care 40:III63-72. 2002
    ..Accurate estimation of medical care costs raises a host of issues, both practical and methodological...
  60. pmc Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, PO Box 19024, Seattle, WA 98109, USA
    Genet Med 8:571-5. 2006
    ..Family history assessment is gaining importance as a potential public health tool to help determine susceptibility to common cancers. Population-based data on the prevalence of having a family history of common cancers are scant...
  61. ncbi request reprint Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996
    H F Huizenga
    Division of General Internal Medicine and Health Services, University of Washington, Veterans Administration Puget Sound Health Care System, Seattle 98108, USA
    Chest 114:1583-7. 1998
    ..To estimate the number of lung volume reduction surgery procedures performed on Medicare enrollees from 1994 to 1996...
  62. ncbi request reprint Methods for reviewing economic evaluations of community preventive services: a cart without a horse?
    S D Ramsey
    Department of Medicine, University of Washington, Seattle, USA
    Am J Prev Med 18:15-7. 2000
    ..In conclusion, the methods for systematic review of economic evaluations in the American Journal of Preventive Medicine are important steps. However, it is advisable to use caution in applying them...
  63. doi request reprint Preference values associated with stage III colon cancer and adjuvant chemotherapy
    Jennie H Best
    University of Washington, Seattle, WA, USA
    Qual Life Res 19:391-400. 2010
    ..To elicit preference values for health states associated with Stage III colon cancer (CRC) and to explore the effect of neuropathy associated with current adjuvant treatment...
  64. ncbi request reprint How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Clin Oncol 25:175-9. 2007
  65. ncbi request reprint Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer
    Steven B Zeliadt
    Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA
    Cancer 106:1865-74. 2006
    ..Considerable progress is needed in helping patients fully understand how to balance the complex issues surrounding prostate cancer treatment decision making...
  66. ncbi request reprint The economic burden of COPD
    S D Sullivan
    Departments of Pharmacy and Health Services, University of Washington, Seattle, WA 98195, USA
    Chest 117:5S-9S. 2000
    ..These trends reflect population aging, smoking patterns, institutional factors, and treatment practices...
  67. ncbi request reprint Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC)
    Josh J Carlson
    Institute for Public Health Genetics, School of Public Health and Community Medicine, University of Washington, Seattle, United States
    Lung Cancer 61:405-15. 2008
    ..Various drug therapies are available for treatment of refractory stage IIIB/IV non-small cell lung cancer (NSCLC), but their comparative economic value is unclear...
  68. ncbi request reprint Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization
    Matthew Kerrigan
    Department of Pharmacy, University of Washington, Seattle, and the Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington 98109, USA
    Med Care 43:1043-8. 2005
    ..Colorectal cancer is relatively frequent among adults of working age, yet few studies have examined treatment, outcomes, and costs for people under 65 years of age with this disease...
  69. ncbi request reprint Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer
    Steven B Zeliadt
    Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    Am J Med 118:850-7. 2005
    ..In this trial, prostate cancer prevalence was reduced by 25%; however, an increase in the number of high-grade tumors among the treatment group necessitates the long-term projection of the likely benefits and costs...
  70. ncbi request reprint Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer
    Josh J Carlson
    School of Public Health and Community Medicine, Institute for Public Health Genetics, University of Washington, Seattle, Washington, USA
    Drugs 68:1105-13. 2008
    ..Given the absence of studies on newer therapeutics and the lack of cost-utility studies, additional studies are warranted...
  71. ncbi request reprint Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999
    Steven B Zeliadt
    Department of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Urology 64:1171-6. 2004
    ..To assess trends in the initial care of nonmetastatic prostate cancer, including the use of primary and adjuvant androgen deprivation therapy (ADT), using population-based treatment claims from 1991 to 1999...
  72. ncbi request reprint Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease
    Vincent S Fan
    Health Services Research and Development Center of Excellence, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108 1597, USA
    Arch Intern Med 167:2345-53. 2007
    ....
  73. ncbi request reprint Quality of life in long term survivors of colorectal cancer
    Scott D Ramsey
    Department of Medicine, University of Washington, Seattle, USA
    Am J Gastroenterol 97:1228-34. 2002
    ..We aimed to determine the quality of life (QOL) for long term survivors of colorectal cancer...
  74. ncbi request reprint Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD
    Vincent S Fan
    Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA 98108 1597, USA
    COPD 4:29-39. 2007
    ..08, 1.02-1.14) independently predicted exacerbations (AUC for full model 0.68). Combining physiologic variables, dyspnea, prior exacerbations and co-morbidity may be useful in identifying patients at high risk for COPD exacerbations...
  75. ncbi request reprint Trends in treatment costs for localized prostate cancer: the healthy screenee effect
    Steven B Zeliadt
    Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Med Care 45:154-9. 2007
    ..We sought to obtain estimates of trends in initial treatment costs during the prostate-specific antigen (PSA) era that account for the changing patient case-mix associated with screening...
  76. ncbi request reprint The limited state of technology assessment for medical devices: facing the issues
    S D Ramsey
    Center for Cost and Outcomes Research, University of Washington, Seattle, WA 98103, USA
    Am J Manag Care 4:SP188-99. 1998
    ....
  77. ncbi request reprint Suboptimal medical therapy in COPD: exploring the causes and consequences
    S D Ramsey
    Departments of Medicine and Health Services, University of Washington, Seattle 98103, USA
    Chest 117:33S-7S. 2000
    ..Without such data, managed care organizations will be reluctant to allocate scarce resources toward expensive guideline implementation programs for individuals with this condition...
  78. ncbi request reprint Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes
    N Chaiyakunapruk
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    J Cardiovasc Risk 8:127-32. 2001
    ..Cost-effectiveness studies of statins in the diabetic population are detailed, along with recommendations for further research...
  79. ncbi request reprint Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS
    T A Lee
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle 98195, USA
    Pharmacoeconomics 19:535-50. 2001
    ..To determine the cost of using systemic therapy to treat newly diagnosed cytomegalovirus (CMV) retinitis in persons with AIDS...
  80. ncbi request reprint Effect of compensation method on the behavior of primary care physicians in managed care organizations: evidence from interviews with physicians and medical leaders in Washington State
    B K Zierler
    University of Washington, Seattle 98195 6410, USA
    Am J Manag Care 4:209-20. 1998
    ..The responses revealed in interviews with physicians and administrative leaders underscored the critical role compensation arrangements play in driving physician satisfaction and behavior...
  81. ncbi request reprint Randomized trial of amplification strategies
    B Yueh
    Surgery Service 112OTO, VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108, USA
    Arch Otolaryngol Head Neck Surg 127:1197-204. 2001
    ..Little is known about quality of life after the use of specific types of hearing aids, so it is difficult to determine whether technologies such as programmable circuits and directional microphones are worth the added expense...
  82. ncbi request reprint Patient recruitment methods to evaluate treatment decision making for localized prostate cancer
    Steven B Zeliadt
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Clin Oncol 33:381-6. 2010
    ..To examine methods for identifying and recruiting prostate cancer patients prior to initiating treatment to gain insight into the treatment decision process and avoid recall bias...
  83. ncbi request reprint Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines
    Benjamin O Anderson
    Department of Surgery, University of Washington, Seattle, 98195, USA
    Breast J 12:S3-15. 2006
    ..Future research is needed to better determine how these guidelines can best be implemented in limited-resource settings...
  84. pmc An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis
    Josh J Carlson
    Institute for Public Health Genetics, School of Public Health and Community Medicine, University of Washington, Washington 98195, USA
    J Gastroenterol Hepatol 24:786-91. 2009
    ..To assess the clinical and economic outcomes of non-invasive testing strategies in the diagnosis of significant liver fibrosis (Metavir score >or= 2) compared with liver biopsy...
  85. doi request reprint Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer
    Megan Dann Fesinmeyer
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Int J Radiat Oncol Biol Phys 78:675-81. 2010
    ..To investigate whether interruptions in radiotherapy are associated with decreased survival in a population-based sample of head-and-neck cancer patients...
  86. ncbi request reprint Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, USA
    Gastroenterology 125:1645-50. 2003
    ....
  87. ncbi request reprint Incorporating economic analysis into clinical practice guidelines: a guide for users
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA
    ACP J Club 137:A11-3. 2002
  88. pmc Lung cancer histology, stage, treatment, and survival in American Indians and Alaska Natives and whites
    Megan Dann Fesinmeyer
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Cancer 116:4810-6. 2010
    ..To the authors' knowledge, no studies to date have investigated whether race-based differences in histology could explain survival disparities...
  89. doi request reprint Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis
    Josh John Carlson
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA 98195, USA
    J Cancer Res Clin Oncol 135:1483-93. 2009
    ....
  90. ncbi request reprint Evidence-based management: using serial firm trials to improve diabetes care quality
    Harold I Goldberg
    University of Washington, Seattle, USA
    Jt Comm J Qual Improv 28:155-66. 2002
    ..The effectiveness of the "computerized firm system" approach to chronic disease CQI was examined, with diabetes as the focus of a 5-year case study...
  91. ncbi request reprint Breast cancer in limited-resource countries: health care systems and public policy
    Benjamin O Anderson
    Department of Surgery, University of Washington, Seattle, 98195, USA
    Breast J 12:S54-69. 2006
    ..This adaptable framework can be used as a tool by policymakers for program planning and research design to make best use of available resources to improve breast health care in a given limited-resource setting...
  92. ncbi request reprint A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment
    David L Veenstra
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Pharmacoeconomics 20:21-30. 2002
    ....
  93. ncbi request reprint Use of alternative therapies by older adults with osteoarthritis
    S D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Arthritis Rheum 45:222-7. 2001
    ..CONCLUSION: Use of and expenditures for alternative care were high among this cohort of older adults with OA. Clinicians may want to inquire about use of these therapies before recommending treatments for this condition...
  94. ncbi request reprint Preliminary treatment considerations among men with newly diagnosed prostate cancer
    Steven B Zeliadt
    Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA, USA
    Am J Manag Care 16:e121-30. 2010
    ..To assess factors that may influence men's preference for surgery versus nonsurgical options among newly diagnosed patients considering treatments for local-stage prostate cancer...
  95. doi request reprint Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial
    Vincent S Fan
    VA Puget Sound Health Care System, Health Services Research and Development Center of Excellence, Seattle, WA, USA
    COPD 5:105-16. 2008
    ..A better understanding of patient factors such as socioeconomic status, depression, anxiety and transportation issues may improve adherence to pulmonary rehabilitation...
  96. ncbi request reprint Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers
    Meira Epplein
    Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 23:4713-8. 2005
    ..As a follow-up to our 1993 survey, we sought to determine how the scope and volume of genetic services has changed between 1993 and 2002...
  97. ncbi request reprint A multifaceted intervention in support of diabetes treatment guidelines: a cont trial
    Irl B Hirsch
    Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, 1959 NE Pacific Street, Box 356176, Seattle, WA 98195, USA
    Diabetes Res Clin Pract 58:27-36. 2002
    ..Providers received didactic training and computerized compliance feedback to support staged diabetes management, an evidenced-based approach to diabetes care...
  98. ncbi request reprint Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trial
    Nancy Neil
    Virginia Mason Medical Center, University of Washington School of Public Health, Seattle, Washington
    J Interv Cardiol 15:249-55. 2002
    ....
  99. doi request reprint The costs of treating breast cancer in the US: a synthesis of published evidence
    Jonathan D Campbell
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Pharmacoeconomics 27:199-209. 2009
    ....
  100. ncbi request reprint The outcomes of the cancer outcomes research symposium: a commentary
    Larry Kessler
    Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20850, USA
    Med Care 40:III104-8. 2002
  101. pmc Economic analyses and clinical practice guidelines: why not a match made in heaven?
    Scott D Ramsey
    J Gen Intern Med 17:235-7. 2002

Research Grants7

  1. COST EFFECTIVENESS OF GENETIC SCREENING FOR COLON CANCER
    Scott Ramsey; Fiscal Year: 2002
    ....
  2. A Genetic Screening Policy Model for Colorectal Cancer
    Scott Ramsey; Fiscal Year: 2004
    ..The model will incorporate QOL information from Aim 2, along with family history, clinical, and screening information from the Seattle CFR. ..
  3. A Genetic Screening Policy Model for Colorectal Cancer
    Scott Ramsey; Fiscal Year: 2005
    ..The model will incorporate QOL information from Aim 2, along with family history, clinical, and screening information from the Seattle CFR. ..
  4. A Genetic Screening Policy Model for Colorectal Cancer
    Scott Ramsey; Fiscal Year: 2006
    ..The model will incorporate QOL information from Aim 2, along with family history, clinical, and screening information from the Seattle CFR. ..
  5. A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
    Scott Ramsey; Fiscal Year: 2007
    ..and the Indian Health Council Inc. ..
  6. A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
    Scott Ramsey; Fiscal Year: 2008
    ..and the Indian Health Council Inc. ..
  7. A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
    Scott D Ramsey; Fiscal Year: 2010
    ..and the Indian Health Council Inc. ..